Pexa-Vec

pexastimogene devacirep · Transgene

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Pexa-Vec, covering 2021-10-26 to 2026-07-14. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma [Phase 2]